Investors in Gilead Sciences can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the American market. Per share the analysts anticipate on a dividend of 2,7 USD per share. The dividend yield is then 4,45 percent. The average dividend yield of the biotech companies is a limited 0,31 percent.
Over the current book year the total revenue will be 24,1 billion USD (consensus estimates). This is slightly more than 2019's revenue of 22,45 billion USD.
The analysts expect for 2020 a net profit of 8,73 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 6,9 USD. Based on this the price/earnings-ratio is 8,79.
Based on the current number of shares Gilead Sciences's market capitalization equals 77,78 billion USD. The Gilead Sciences stock was the past 12 months quite unstable. Since last October the stock is 4 percent lower. This year the stock price moved between 60 and 86 dollar.
Click here for dividend Gilead Sciences. At 18.41 the stock trades 0,9 percent higher at 60,67 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.